Telavancin labels and packages: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Telavancin}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION...")
 
No edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{chetan}}
{{CMG}}; {{AE}} {{chetan}}


==Labels And Packages==


===PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 250 MG/VIAL LABEL===
NDC 0469-3525-30
1 Vial
Vibativ™
(telavancin hydrochloride)
Equivalent to 250 mg telavancin
Rx only
Astellas
{|
|-
| [[File:|800px|thumb]]
|-
|}
===PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 250 MG/VIAL CARTON===
NDC 0469-3525-30
1 Carton containing 1 Vial of 250 mg
Vibativ™
(telavancin hydrochloride)
Equivalent to 250 mg telavancin per vial
Rx only
Astellas
{|
|-
| [[File:|800px|thumb]]
|-
|}
===PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 750 MG/VIAL LABEL===
NDC 0469-3575-50
1 Vial
Vibativ™
(telavancin hydrochloride)
Equivalent to 750 mg telavancin
Rx only
Astellas
{|
|-
| [[File:|800px|thumb]]
|-
|}
===PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 750 MG/VIAL CARTON===
NDC 0469-3575-50
1 Carton containing 1 Vial of 750 mg
Vibativ™
(telavancin hydrochloride)
Equivalent to 750 mg telavancin per vial
Rx only
Astellas<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e7c066c-0950-47ce-899d-76881d80c492 | publisher =  | date =  | accessdate = }}</ref>
{|
|-
| [[File:|800px|thumb]]
|-
|}


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e7c066c-0950-47ce-899d-76881d80c492 | publisher =  | date =  | accessdate = }}</ref>




Latest revision as of 00:08, 10 January 2014

Telavancin
Vibativ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels And Packages

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 250 MG/VIAL LABEL

NDC 0469-3525-30

1 Vial

Vibativ™

(telavancin hydrochloride)

Equivalent to 250 mg telavancin

Rx only

Astellas

[[File:|800px|thumb]]

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 250 MG/VIAL CARTON

NDC 0469-3525-30

1 Carton containing 1 Vial of 250 mg

Vibativ™

(telavancin hydrochloride)

Equivalent to 250 mg telavancin per vial

Rx only

Astellas

[[File:|800px|thumb]]

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 750 MG/VIAL LABEL

NDC 0469-3575-50

1 Vial

Vibativ™

(telavancin hydrochloride)

Equivalent to 750 mg telavancin

Rx only

Astellas

[[File:|800px|thumb]]


PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 750 MG/VIAL CARTON

NDC 0469-3575-50

1 Carton containing 1 Vial of 750 mg

Vibativ™

(telavancin hydrochloride)

Equivalent to 750 mg telavancin per vial

Rx only

Astellas[1]


[[File:|800px|thumb]]


References

  1. ↑ "VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US INC.]".

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Telavancin_labels_and_packages&oldid=931100"